Why the study?
Are the +45T>G and +276G>T single nucleotide polymorphisms of the adiponectin gene associated with coronary artery disease in type 2 diabetic patients?
Are the +45T>G and +276G>T single nucleotide polymorphisms of the adiponectin gene associated with coronary artery disease in type 2 diabetic patients?
Answers are grounded in this paper and cite their sources.
The +276 G>T polymorphism of the adiponectin gene is a significant determinant of CAD risk in type 2 diabetic patients, with the T/T genotype conferring a protective effect.
OBJECTIVE: Two single nucleotide polymorphisms (SNPs) at the adiponectin locus (+45T>G and +276G>T) have been associated with low circulating adiponectin levels, insulin resistance, and type 2 diabetes. We investigated whether these genetic markers are determinants of coronary artery disease (CAD) in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A total of 376 consecutive type 2 diabetic patients were studied: 142 case subjects with coronary stenosis >50% or previous myocardial infarction and 234 control subjects with no symptoms, no electrocardiogram (ECG) signs of myocardial ischemia, and a normal ECG stress test (n = 189) and/or (n = 45) with coronary stenosis <or=50%. RESULTS: No association with CAD was observed for the +45 SNP (P = 0.48). By contrast, a significant association was observed for the +276 SNP, with T/T homozygotes having a lower risk of CAD than carriers of other genotypes (adjusted odds ratio [OR] 0.13 [95% CI 0.037-0.46], P = 0.002). A similarly protective effect of the +276 T/T genotype was observed in 110 case and 45 control subjects for whom the CAD status had been determined by angiography (0.04 [0.006-0.30], P = 0.002). Serum adiponectin, although clearly related to several features of the proatherogenic/insulin-resistant phenotype, was not different between control subjects and CAD patients (26 +/- 17 vs. 25 +/- 13 microg/ml). CONCLUSIONS: In conclusion, the +276 G>T polymorphism is a determinant of CAD risk in type 2 diabetic patients. This marker may assist in the identification of diabetic individuals at especially high risk of CAD, so that preventive programs can be targeted at these subjects.
No takes yet. Share an insight, caveat, or question.
Bacci et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: